Results 61 to 70 of about 9,052 (130)

In vitro Studies: Inhibition of Nevirapine Metabolism by Nortriptyline in Hepatic Microsomes

Bio-Protocol, 2015
One of the most prevalent and interfering psychosocial comorbidities of HIV infection is clinical depression (22 to 45%). For this reason, a study of a possible interaction between the nonnucleoside reverse transcriptase inhibitor nevirapine (NVP) and ...
Iris Usach, José-Esteban Peris
doaj   +1 more source

Combination of Citalopram and Nortriptyline in Treatment of Moderate to Severe Major Depression: A Double-blind, Placebo- controlled Trial [PDF]

Iranian Journal of Psychiatry, 2006
Objective: Depression is a major health problem, which is not only underrecognized and undertreated, but is also associated with significant morbidity and mortality.
Mohammad Reza Mohammadi, Abbas Ali Nasehi, Nastaran Habibi, Firoozeh Raisi   +3 more
doaj   +1 more source

Effect of topical application of amitriptyline and nortriptyline on irreversible pulpitis pain in teeth with failed pulpal anesthesia after a successful inferior alveolar nerve block: A randomized clinical trial

Dental Research Journal
Background: No consensus has been reached on the effect of topical application of amitriptyline and nortriptyline on irreversible pulpitis pain in teeth with failed pulpal anesthesia after a successful inferior alveolar nerve (IAN) block.
Armita Vali Sichani, Hossein Baharian, Navid Yaraghi, Zahra Khosravani, Asana Vali Sichani   +4 more
doaj   +1 more source

Nocturnal panic attacks

Arquivos de Neuro-Psiquiatria, 2002
The panic-respiration connection has been presented with increasing evidences in the literature. We report three panic disorder patients with nocturnal panic attacks with prominent respiratory symptoms, the overlapping of the symptoms with the sleep ...
Lopes Fabiana L., Nardi Antonio E., Nascimento Isabella, Valença Alexandre M., Zin Walter A   +4 more
doaj  

Use of combinatorial pharmacogenomic testing in two cases from community psychiatry

Pharmacogenomics and Personalized Medicine, 2016
Eve S Fields,1 Raymond A Lorenz,2 Joel G Winner2 1Northwest Center for Community Mental Health, Reston, VA, USA; 2Assurex Health, Mason, OH, USA Abstract: This report describes two cases in which pharmacogenomic testing was utilized to guide medication ...
Fields ES, Lorenz RA, Winner JG
doaj  

Exploring the efficacy of nortriptyline, buspirone, and Ginkgo biloba extract as alternative medications in ADHD management: a systematic review

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Background Attention-Deficit/Hyperactivity Disorder (ADHD) is commonly managed with stimulant medications such as methylphenidate and non-stimulant options like atomoxetine.
Ramin Abdi Dezfouli, Soroush Hashemzadeh, Anita Saleh Mohammadzadeh   +2 more
doaj   +1 more source

A real-life study of the effectiveness of different pharmacological approaches to the treatment of smoking cessation: re-discussing the predictors of success

Clinics, 2011
OBJECTIVE: To evaluate the effectiveness of nicotine replacement therapy (NRT), bupropion, nortriptyline and combination therapy and describe factors associated with treatment success.
Gustavo Faibischew Prado, Elisa Maria Siqueira Lombardi, Marco Antônio Bussacos, Frederico Leon Arrabal-Fernandes, Mário Terra-Filho, Ubiratan de Paula Santos   +5 more
doaj  

CYP2D6 Metabolizer Status Does Not Predict Response or Tolerability of Low-Dose Nortriptyline for Irritable Bowel Syndrome With Diarrhea. [PDF]

Gastro Hep Adv
Staller K, Clukey J, Madva EN, Healy BC, Lee M, Gala MK.   +5 more
europepmc   +1 more source

Prolonged Tricyclic Antidepressant Toxicity in a Pediatric Patient: The Importance of Understanding the Multifactorial Nature of Amitriptyline Metabolism. [PDF]

Cureus
Navarro AW, Sahhar H.
europepmc   +1 more source

Placebo-controlled three-armed pilot trial of Escitalopram or Nortriptyline for depressive symptoms in Parkinson's disease (ADepT-PD). [PDF]

J Neural Transm (Vienna)
Schrag A, Embleton-Thirsk A, Carroll C, Serfaty M, Duncan G, Molloy S, Whipps J, McLennan B, Lewis G.   +8 more
europepmc   +1 more source